These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1388254

  • 1. The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse--3. Quinine.
    Wang H, Grahame-Smith DG.
    Neuropharmacology; 1992 May; 31(5):425-31. PubMed ID: 1388254
    [Abstract] [Full Text] [Related]

  • 2. The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse--1. Rubidium.
    Wang H, Grahame-Smith DG.
    Neuropharmacology; 1992 May; 31(5):413-9. PubMed ID: 1382243
    [Abstract] [Full Text] [Related]

  • 3. The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse--2. Caesium.
    Wang H, Grahame-Smith DG.
    Neuropharmacology; 1992 May; 31(5):421-4. PubMed ID: 1528394
    [Abstract] [Full Text] [Related]

  • 4. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM, Green AR.
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [Abstract] [Full Text] [Related]

  • 5. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR, DeSouza RJ, Davies EM, Cross AJ.
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [Abstract] [Full Text] [Related]

  • 6. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR, Hall JE, Rees AR.
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [Abstract] [Full Text] [Related]

  • 7. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
    Backus LI, Sharp T, Grahame-Smith DG.
    Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
    [Abstract] [Full Text] [Related]

  • 8. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
    Berendsen HH, Broekkamp CL.
    Psychopharmacology (Berl); 1991 Aug; 105(2):219-24. PubMed ID: 1839064
    [Abstract] [Full Text] [Related]

  • 9. Induction of purposeless chewing behaviour in rats by 5-HT agonist drugs.
    Stewart BR, Jenner P, Marsden CD.
    Eur J Pharmacol; 1989 Mar 14; 162(1):101-7. PubMed ID: 2524394
    [Abstract] [Full Text] [Related]

  • 10. The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats.
    Goodwin GM, De Souza RJ, Green AR.
    Psychopharmacology (Berl); 1986 Mar 14; 89(3):382-7. PubMed ID: 2941817
    [Abstract] [Full Text] [Related]

  • 11. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 14; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 12. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J, Sugimoto Y, Horisaka K.
    Eur J Pharmacol; 1988 Sep 23; 154(3):299-304. PubMed ID: 2976671
    [Abstract] [Full Text] [Related]

  • 13. The effects of acute and repeated administration of T3 to mice on 5-HT1 and 5-HT2 function in the brain and its influence on the actions of repeated electroconvulsive shock.
    Heal DJ, Smith SL.
    Neuropharmacology; 1988 Dec 23; 27(12):1239-48. PubMed ID: 2977427
    [Abstract] [Full Text] [Related]

  • 14. Effect of isolation rearing on 5-HT agonist-induced responses in the rat.
    Wright IK, Ismail H, Upton N, Marsden CA.
    Psychopharmacology (Berl); 1991 Dec 23; 105(2):259-63. PubMed ID: 1839066
    [Abstract] [Full Text] [Related]

  • 15. The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Goodwin GM, De Souza RJ, Green AR, Heal DJ.
    Psychopharmacology (Berl); 1987 Dec 23; 91(4):506-11. PubMed ID: 2954179
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological studies on serotonin-mediated behaviour.
    Green AR.
    J Physiol (Paris); 1981 Dec 23; 77(2-3):437-47. PubMed ID: 6457143
    [Abstract] [Full Text] [Related]

  • 17. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats.
    Jackson HC, Kitchen I.
    Neuropharmacology; 1989 Jun 23; 28(6):635-42. PubMed ID: 2526930
    [Abstract] [Full Text] [Related]

  • 18. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
    Eide PK, Hole K, Berge OG, Broch OJ.
    Brain Res; 1988 Feb 02; 440(1):42-52. PubMed ID: 2965956
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome.
    Smith LM, Peroutka SJ.
    Pharmacol Biochem Behav; 1986 Jun 02; 24(6):1513-9. PubMed ID: 2942947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.